BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 7898493)

  • 61. Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional immunoglobulin heavy chain rearrangement.
    Grawunder U; Leu TM; Schatz DG; Werner A; Rolink AG; Melchers F; Winkler TH
    Immunity; 1995 Nov; 3(5):601-8. PubMed ID: 7584150
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differential regulation of V(D)J recombination during development of avian B and T cells.
    Pickel JM; McCormack WT; Chen CH; Cooper MD; Thompson CB
    Int Immunol; 1993 Aug; 5(8):919-27. PubMed ID: 8398986
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reexpression of RAG-1 and RAG-2 genes in activated mature mouse B cells.
    Hikida M; Mori M; Takai T; Tomochika K; Hamatani K; Ohmori H
    Science; 1996 Dec; 274(5295):2092-4. PubMed ID: 8953042
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Up-regulation of recombination activating gene expression by signal transduction through the surface Ig receptor.
    Verkoczy LK; Stiernhdm BJ; Berinstein NL
    J Immunol; 1995 May; 154(10):5136-43. PubMed ID: 7537300
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Stable expression of immunoglobulin gene V(D)J recombinase activity by gene transfer into 3T3 fibroblasts.
    Schatz DG; Baltimore D
    Cell; 1988 Apr; 53(1):107-15. PubMed ID: 3349523
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rch1, a protein that specifically interacts with the RAG-1 recombination-activating protein.
    Cuomo CA; Kirch SA; Gyuris J; Brent R; Oettinger MA
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6156-60. PubMed ID: 8016130
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Enhancer control of local accessibility to V(D)J recombinase.
    McMurry MT; Hernandez-Munain C; Lauzurica P; Krangel MS
    Mol Cell Biol; 1997 Aug; 17(8):4553-61. PubMed ID: 9234713
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Targeted transposition by the V(D)J recombinase.
    Lee GS; Neiditch MB; Sinden RR; Roth DB
    Mol Cell Biol; 2002 Apr; 22(7):2068-77. PubMed ID: 11884595
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The gene loci for immunoglobulin heavy chains in precursor B cell lines from a patient with severe combined immunodeficiency appear able to participate in DNA rearrangement but have a germ-line configuration.
    Kamachi Y; Ichihara Y; Tsuge I; Abe T; Torii S; Kurosawa Y; Matsuoka H
    Eur J Immunol; 1993 Jun; 23(6):1401-4. PubMed ID: 8500535
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immunoglobulin D(H) recombination signal sequence targeting: effect of D(H) coding and flanking regions and recombination partner.
    VanDyk LF; Wise TW; Moore BB; Meek K
    J Immunol; 1996 Nov; 157(9):4005-15. PubMed ID: 8892634
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dual role of RAG2 in V(D)J recombination: catalysis and regulation of ordered Ig gene assembly.
    Kirch SA; Rathbun GA; Oettinger MA
    EMBO J; 1998 Aug; 17(16):4881-6. PubMed ID: 9707447
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibition of serine/threonine protein phosphatases enhances agonist-stimulated cAMP accumulation in UMR 106 osteoblast-like cells.
    Kovacs CS; Chik CL; Li B; Karpinski E; Ho AK
    Mol Cell Endocrinol; 1995 Apr; 110(1-2):9-16. PubMed ID: 7545625
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Analysis of secondary V(D)J rearrangements in mature, peripheral T cells of ataxia-telangiectasia heterozygotes.
    Lantelme E; Turinetto V; Mantovani S; Marchi A; Regazzoni S; Porcedda P; De Marchi M; Giachino C
    Lab Invest; 2003 Oct; 83(10):1467-75. PubMed ID: 14563948
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The bounty of RAGs: recombination signal complexes and reaction outcomes.
    Swanson PC
    Immunol Rev; 2004 Aug; 200():90-114. PubMed ID: 15242399
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Gene-targeted deletion and replacement mutations of the T-cell receptor beta-chain enhancer: the role of enhancer elements in controlling V(D)J recombination accessibility.
    Bories JC; Demengeot J; Davidson L; Alt FW
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7871-6. PubMed ID: 8755569
    [TBL] [Abstract][Full Text] [Related]  

  • 76. RAG1 and RAG2 in V(D)J recombination and transposition.
    Fugmann SD
    Immunol Res; 2001; 23(1):23-39. PubMed ID: 11417858
    [TBL] [Abstract][Full Text] [Related]  

  • 77. RAG: a recombinase diversified.
    Matthews AG; Oettinger MA
    Nat Immunol; 2009 Aug; 10(8):817-21. PubMed ID: 19621044
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Roles of the "dispensable" portions of RAG-1 and RAG-2 in V(D)J recombination.
    Steen SB; Han JO; Mundy C; Oettinger MA; Roth DB
    Mol Cell Biol; 1999 Apr; 19(4):3010-7. PubMed ID: 10082568
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vivo transposition mediated by V(D)J recombinase in human T lymphocytes.
    Messier TL; O'Neill JP; Hou SM; Nicklas JA; Finette BA
    EMBO J; 2003 Mar; 22(6):1381-8. PubMed ID: 12628930
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Development of B cells in scid mice with immunoglobulin transgenes: implications for the control of V(D)J recombination.
    Chang Y; Bosma GC; Bosma MJ
    Immunity; 1995 Jun; 2(6):607-16. PubMed ID: 7796294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.